Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
12 studies found for:    Open Studies | "Chickenpox"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery
Conditions: Varicella;   Hepatitis A
Interventions: Biological: Varicella Vaccine;   Biological: Hepatitis A Vaccine
2 Recruiting Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
Conditions: Liver Disease;   Liver Transplantation;   Varicella
Intervention: Biological: Vaccination with VZV vaccine
3 Unknown  Efficacy of TCA Effect on Varicella Atrophic Scars
Condition: Atrophic Varicella Scar
Intervention: Drug: 70% trichloroacetic acid
4 Recruiting The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Condition: Varicella
Interventions: Biological: HBV-3;   Biological: HBV-6;   Biological: varicella-3;   Biological: varicella-6
5 Recruiting Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
Condition: Persistence of Varicella Immunity
Intervention: Biological: Varicella vaccine
6 Unknown  Zostavax in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Varicella Zoster
Intervention: Drug: Zostavax (varicella zoster virus) vaccine
7 Not yet recruiting Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults
Condition: Varicella (Chicken Pox)
Interventions: Biological: MG1111;   Biological: VARIVAX
8 Recruiting VZV Vaccine for Hematopoietic Stem Cell Transplantation
Condition: Varicella Zoster Infection
Interventions: Biological: Zostavax;   Biological: Normal Saline
9 Not yet recruiting Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMR  Bio-Manguinhos;   Biological: MMR GlaxoSmithKline
10 Unknown  Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Conditions: Immunosenescence;   Shingles
Intervention: Biological: Varicella Zoster Virus Vaccine (Zostavax)
11 Recruiting A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Placebo
12 Recruiting iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma/VEGAS
Condition: Sarcomas
Interventions: Genetic: GD2 T cells;   Biological: VZV vaccine

Indicates status has not been verified in more than two years